Soligenix Inc (SNGX)

$1.37 -0.01 (-0.72%)
Market Cap 5.91M
Revenue (ttm) 120,000.00
Net Income (ttm) -8.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,891.67%
Debt to Equity Ratio 0.00
Volume 1,384,200
Avg Vol 13,519,880
Day's Range N/A - N/A
Shares Out 4.29M
Stochastic %K 29%
Beta 1.95
Analysts Strong Buy
Price Target $17.50

Company Profile

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 538 8200
Fax: 609 452 6467
Address:
29 Emmons Drive, Suite B-10, Princeton, United States
mike537
mike537 Oct. 6 at 10:39 PM
$SNGX only up from here
0 · Reply
BATMAN666
BATMAN666 Oct. 6 at 9:26 PM
$SNGX
0 · Reply
SWCtrader
SWCtrader Oct. 6 at 4:43 PM
$SNGX I like the Schaber buy, but he really didn't buy that much 🤔
0 · Reply
Neil2909
Neil2909 Oct. 6 at 3:56 PM
$SNGX
0 · Reply
liadanielle
liadanielle Oct. 6 at 3:41 PM
$SNGX
0 · Reply
Nvidiagh
Nvidiagh Oct. 6 at 3:08 PM
$JOBY $SNGX is way undervalued $NVDA to 178 area $
0 · Reply
Johnny_Tubesteak
Johnny_Tubesteak Oct. 6 at 2:09 PM
$SNGX Limit set at 1.33. Let's see if this turd gets a fill. This thing can go hard again. Bullish to the 5th power.
0 · Reply
peepthestamp
peepthestamp Oct. 6 at 1:35 PM
$CANF $JXG $MASK $SNGX $SOPA -Aging Well 👀
0 · Reply
peepthestamp
peepthestamp Oct. 5 at 8:34 PM
$SNGX $SOPA $MASK $CANF $JXG
0 · Reply
ChartChartist
ChartChartist Oct. 4 at 7:08 PM
$YAAS could be good here lets see $SNGX into the gap 1.6 next $XPON news ready $PAVS the hottest setup since firestorm 2022 ; everyone is slapping 4am monday i hear, get your bank
1 · Reply
Latest News on SNGX
Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Sep 30, 2025, 7:30 AM EDT - 6 days ago

Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix Announces Closing of $7.5 Million Public Offering

Sep 29, 2025, 4:05 PM EDT - 7 days ago

Soligenix Announces Closing of $7.5 Million Public Offering

Soligenix Announces Pricing of $7.5 Million Public Offering

Sep 26, 2025, 6:33 AM EDT - 10 days ago

Soligenix Announces Pricing of $7.5 Million Public Offering

Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor

Sep 23, 2025, 7:30 AM EDT - 13 days ago

Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

Sep 4, 2025, 7:30 AM EDT - 4 weeks ago

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 7:30 AM EDT - 4 weeks ago

Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Why Is Soligenix Stock Soaring On Monday?

Aug 18, 2025, 1:03 PM EDT - 7 weeks ago

Why Is Soligenix Stock Soaring On Monday?

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

Aug 18, 2025, 7:30 AM EDT - 7 weeks ago

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results

Aug 14, 2025, 7:30 AM EDT - 7 weeks ago

Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results

NetworkNewsAudio Announces Audio Press Release (APR) on Promising First-Line Therapy for Rare Skin Cancer

Aug 8, 2025, 8:30 AM EDT - 2 months ago

NetworkNewsAudio Announces Audio Press Release (APR) on Promising First-Line Therapy for Rare Skin Cancer

Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet's Disease

Jul 31, 2025, 7:30 AM EDT - 2 months ago

Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet's Disease

Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones

Jul 8, 2025, 7:30 AM EDT - 3 months ago

Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones

Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions

Jul 1, 2025, 7:30 AM EDT - 3 months ago

Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions

Soligenix Highlights Dr. Ellen Kim's Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials

Jun 6, 2025, 9:37 AM EDT - 4 months ago

Soligenix Highlights Dr. Ellen Kim's Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials

Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results

May 9, 2025, 7:30 AM EDT - 5 months ago

Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results

Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks

Apr 14, 2025, 7:30 AM EDT - 6 months ago

Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks

IBN Initiates Coverage of Soligenix Inc.

Mar 25, 2025, 8:30 AM EDT - 6 months ago

IBN Initiates Coverage of Soligenix Inc.

Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants

Mar 25, 2025, 7:30 AM EDT - 6 months ago

Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants

Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results

Mar 21, 2025, 7:30 AM EDT - 7 months ago

Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results

HyBryte™ Treatment Studies Presented at Two Medical Conferences in March

Mar 6, 2025, 7:30 AM EST - 7 months ago

HyBryte™ Treatment Studies Presented at Two Medical Conferences in March

Soligenix to Present at BIO CEO & Investor Conference

Feb 4, 2025, 7:30 AM EST - 8 months ago

Soligenix to Present at BIO CEO & Investor Conference

Soligenix to Present at Upcoming Investor Conferences

Jan 16, 2025, 7:30 AM EST - 9 months ago

Soligenix to Present at Upcoming Investor Conferences

HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Jan 14, 2025, 7:30 AM EST - 9 months ago

HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Dec 16, 2024, 7:30 AM EST - 10 months ago

Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment

Dec 2, 2024, 7:30 AM EST - 11 months ago

HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Nov 19, 2024, 7:30 AM EST - 11 months ago

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix to Present at November 21st Virtual Investor Summit Microcap Event

Nov 15, 2024, 7:30 AM EST - 11 months ago

Soligenix to Present at November 21st Virtual Investor Summit Microcap Event

Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease

Nov 14, 2024, 7:15 AM EST - 11 months ago

Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results

Nov 8, 2024, 7:30 AM EST - 11 months ago

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin

Oct 22, 2024, 7:30 AM EDT - 1 year ago

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin

Soligenix Invited to Present at Upcoming Investor Conferences

Oct 16, 2024, 7:30 AM EDT - 1 year ago

Soligenix Invited to Present at Upcoming Investor Conferences

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference

Oct 7, 2024, 7:30 AM EDT - 1 year ago

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference

Soligenix Announces Partnership with Sterling Pharma Solutions

Oct 3, 2024, 7:30 AM EDT - 1 year ago

Soligenix Announces Partnership with Sterling Pharma Solutions

Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Sep 20, 2024, 9:00 AM EDT - 1 year ago

Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Aug 16, 2024, 9:00 AM EDT - 1 year ago

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

AREC

Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results

Aug 9, 2024, 7:30 AM EDT - 1 year ago

Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

Jul 15, 2024, 10:16 AM EDT - 1 year ago

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

Soligenix stock rallies 400% on positive HyBryte trial results

Jul 9, 2024, 12:46 PM EDT - 1 year ago

Soligenix stock rallies 400% on positive HyBryte trial results

Crude Oil Down 1%; Soligenix Shares Surge

Jul 9, 2024, 12:11 PM EDT - 1 year ago

Crude Oil Down 1%; Soligenix Shares Surge

Nano-Cap Soligenix Stock Surges Over 200% On Tuesday, Here's Why

Jul 9, 2024, 11:38 AM EDT - 1 year ago

Nano-Cap Soligenix Stock Surges Over 200% On Tuesday, Here's Why

Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Jul 9, 2024, 7:30 AM EDT - 1 year ago

Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma

Jun 25, 2024, 7:30 AM EDT - 1 year ago

Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

Jun 14, 2024, 7:30 AM EDT - 1 year ago

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jun 7, 2024, 9:00 AM EDT - 1 year ago

Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

STSS

Soligenix Announces Reverse Stock Split

May 31, 2024, 7:30 AM EDT - 1 year ago

Soligenix Announces Reverse Stock Split

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

May 29, 2024, 7:30 AM EDT - 1 year ago

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

May 24, 2024, 7:30 AM EDT - 1 year ago

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split

May 23, 2024, 7:30 AM EDT - 1 year ago

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split

mike537
mike537 Oct. 6 at 10:39 PM
$SNGX only up from here
0 · Reply
BATMAN666
BATMAN666 Oct. 6 at 9:26 PM
$SNGX
0 · Reply
SWCtrader
SWCtrader Oct. 6 at 4:43 PM
$SNGX I like the Schaber buy, but he really didn't buy that much 🤔
0 · Reply
Neil2909
Neil2909 Oct. 6 at 3:56 PM
$SNGX
0 · Reply
liadanielle
liadanielle Oct. 6 at 3:41 PM
$SNGX
0 · Reply
Nvidiagh
Nvidiagh Oct. 6 at 3:08 PM
$JOBY $SNGX is way undervalued $NVDA to 178 area $
0 · Reply
Johnny_Tubesteak
Johnny_Tubesteak Oct. 6 at 2:09 PM
$SNGX Limit set at 1.33. Let's see if this turd gets a fill. This thing can go hard again. Bullish to the 5th power.
0 · Reply
peepthestamp
peepthestamp Oct. 6 at 1:35 PM
$CANF $JXG $MASK $SNGX $SOPA -Aging Well 👀
0 · Reply
peepthestamp
peepthestamp Oct. 5 at 8:34 PM
$SNGX $SOPA $MASK $CANF $JXG
0 · Reply
ChartChartist
ChartChartist Oct. 4 at 7:08 PM
$YAAS could be good here lets see $SNGX into the gap 1.6 next $XPON news ready $PAVS the hottest setup since firestorm 2022 ; everyone is slapping 4am monday i hear, get your bank
1 · Reply
PLX_BULLS
PLX_BULLS Oct. 4 at 1:43 AM
$SNGX when’s the next data read out for the P2s? The SGXs.
0 · Reply
mike537
mike537 Oct. 4 at 1:37 AM
$SNGX added today
0 · Reply
MissFred
MissFred Oct. 3 at 11:45 PM
$RELI $SNGX $TGL
1 · Reply
mike537
mike537 Oct. 3 at 10:44 PM
$SNGX https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=319493013&type=HTML&symbol=SNGX&cdn=a983ea677854a4cdefe89c428576cd68&companyName=Soligenix+Inc.&formType=4&dateFiled=2025-10-03
0 · Reply
OTCshithead
OTCshithead Oct. 3 at 8:41 PM
$EVAX The gift that keeps on giving 🙏 congrats bulls $SNGX Holding ⏳️ $GME holding⏳️ $KIDZ holding ⏳️
1 · Reply
jeco
jeco Oct. 3 at 7:49 PM
$SNGX $RELI Have an awesome weekend folks and do yourselves a favor; disconnect from as much technology as you can. Hang out with family. Go outside; even if it's raining. Gotta remember to live our lives. Trading will consume you if you're not careful. In @MS_Tammy I trust. See ya Monday.
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Oct. 3 at 7:20 PM
$SNGX CEO purchased 15,132 shares at $1.32 for a total of $20,000. SCHABER CHRISTOPHER J now owns 15,511 shares. https://ceo-buys.com
0 · Reply
OTCshithead
OTCshithead Oct. 3 at 6:34 PM
$GME $SNGX $KIDZ Main holds for now ⏳️
0 · Reply
Nvidiagh
Nvidiagh Oct. 3 at 6:01 PM
$SNGX magical 1.32
0 · Reply
BARCODES_
BARCODES_ Oct. 3 at 5:43 PM
I recommend you Follow this @MomentumZeus below if you like to load those low float runners before they go crazy! Holding some $SMX $SNGX $ELPW $RCT $BNAI swings over weekend <3
0 · Reply
hafsaw
hafsaw Oct. 3 at 5:43 PM
$SNGX $RELI How u see reli ? I ve 10 thousand shares at 1.29 . So can u guide me when to come out ? Do u think it ll touch 2 dollars??
0 · Reply
MS_Tammy
MS_Tammy Oct. 3 at 5:41 PM
$SNGX Remember as always we were here first.. Because we do our homework properly before we go into a trade.. Insider bought 15k shares at $1.32 yesterday.which means my PT was absolutely accurate.. and next to go is $RELI imo..
2 · Reply